News | April 19, 2026
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
